newsfilter
← Latest News
ClinicalTrials.gov·

Ph3 Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP) - NCT04562766

Sustained Increase in Platelet Counts (Efficacy Outcome Measure), Incidence of Treatment Emergent Adverse Events (Safety Outcome Measure)